|View printer-friendly version|
|Philip Morris International Welcomes Strong Interest for PMI IMPACT|
Global Initiative against Illegal Trade and Related Crimes Receives 157 Applications in Second Funding Round
The applications come from a range of government agencies, public
universities, private companies, and not-for-profit organizations across
56 countries in
“The Expert Council is encouraged by the substantial number of
responses to our invitation for expressions of interest in combatting
illegal trade in all its forms. It is gratifying to receive such
sustained support for the initiative taken by PMI IMPACT to get all
relevant stakeholders to work together,” stated
The second funding round of PMI IMPACT focuses on projects that will tackle converging forms of illegal trade such as the smuggling and counterfeiting of goods, human trafficking, and the trade in drugs, arms, and wildlife. This round also examines the interlinks of illegal trade with related crimes, including corruption, money laundering, and organized criminal networks.
“We would like to thank all applicants for their proposals. Our hope
is that PMI IMPACT will be a global enabler for innovative projects
against illegal trade, and we are encouraged to see this initiative
materialize and evolve year after year” stated
Following the review of the expressions of interest, selected applicants
will be invited to submit their full project proposals in early 2018 for
further evaluation and final selection by the
PMI has pledged
More information on the initiative is available on the PMI IMPACT website.
PMI is a leading international tobacco company, with six of the world's top 15 international brands and products sold in more than 180 markets. In addition to the manufacture and sale of cigarettes, including Marlboro, the number one global cigarette brand, and other tobacco products, PMI is engaged in the development and commercialization of reduced-risk products (“RRPs”). RRPs is the term PMI uses to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continued smoking. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and industry-leading scientific substantiation, PMI aims to provide an RRP portfolio that meets a broad spectrum of adult smoker preferences and rigorous regulatory requirements. For more information, see PMI and PMI Science.